Title: Woan-jen Lee: Innovator in Cancer Treatment
Introduction
Woan-jen Lee is an inventor based in Yonghe City, Taiwan. He has made significant contributions to the field of cancer treatment through his innovative research. Although he currently holds no granted patents, his work is noteworthy for its potential impact on medical science.
Latest Patent Applications
Woan-jen Lee's latest patent application is titled "Compositions and Methods of Using CRMP-1 and Its Fragments for Treating Cancer." This application discloses active fragments of hCRMP1 that are capable of inhibiting cell proliferation, invasive activity, and metastasis of cancer. The methods described can also be used prior to, or in combination with, the administration of a chemotherapy agent. Additionally, the application includes vectors capable of expressing hCRMP1, variants of hCRMP1, fragments of hCRMP1, and/or variants of fragments of hCRMP1.
Conclusion
Woan-jen Lee's research and patent application reflect his dedication to advancing cancer treatment methodologies. His innovative approach may pave the way for new therapeutic options in oncology.